43 results
Page 2 of 3
6-K
EX-1.1
j52f6ddumqj9u2
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.2
atwzjyu9
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
s14h24j
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
x2o6hx5 ql
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-4.1
o1p8e9ug vclk
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
ruzy3nq
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
oykf2
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
wum98jjcykb4p0 qfd
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
81whp
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
424B3
emz24oh bc7v
10 Jul 19
Prospectus supplement
8:18am
F-3
desyq5ic 0x9atrz
28 Jun 19
Shelf registration (foreign)
9:48am
6-K
EX-99.2
a0cbj qvafwk3
20 May 19
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
dhj9jd oy
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
af1l2la
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
20kqgwiu210k
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
zma vr7x502
19 Nov 18
Agreement and Plan of Merger
4:34pm